Indian pharma market grows 12.1% in July.

July IPM sales reached ₹23,193 crore. Cardiac and anti-diabetic therapies led growth; GI and anti-infectives expanded. Investors assess volumes, launches, pricing, regulation and revenue visibility. July 2026 growth: 12.1%. Broad-based demand may improve sector visibility, while execution and regulation remain relevant.